"Designing Growth Strategies is in our DNA"
Hematology is the branch of medicine which deals with blood and blood disorders, thus hematology diagnostics help the medical professionals to diagnose and investigate potential blood disorders. Some of the examples of blood disorders include the various types of anemia, the several forms of blood cancer, thalassemia, malaria, hemophilia, deep venous thrombosis, von Willebrand disease amongst others.
The causes of blood disorders include genetic mutation, exposure to toxins, nutritional deficiency, infections, and other illnesses. Some of the diagnostic instruments include hematology analyzers, plasma protein analyzers, ESR analyzers, hemostasis analyzers, coagulation/ micro-coagulation analyzers. A number of factors are expected to contribute to the growth of the hematology diagnostics market. The Leukemia and Lymphoma Society has stated that leukemia, lymphoma, and myeloma are expected to account for 10% of the estimated 1,735,350 new cancer cases diagnosed in the U.S. in 2018.
To get information on various segments, share your queries with us
Another prevalent class of blood disorders is anemia, which the World Health Organization (WHO) estimates affects about 40.1% of pregnant women globally. The growing incidences of blood disorders, the growth of health infrastructure in developing nations, the growing aging population, and technological advances are some of the factors expected to drive the market’s growth.
One of the key drivers of the growth in the market is the prevalence of hematology disorders especially the occurrence of a range of blood cancers such as leukemia and also the ability to detect the presence of inflammation in the body through the measurement of the Erythrocyte Sedimentation Rate (ESR). These factors are expected to considerably contribute to the growth of the market. Owing to the growth of factors which causes blood disorders such as mutation of genes, the heightened levels of pollution, the absence of essential nutrients in an individual and the rising instances of other illnesses, the market for hematology diagnostics is anticipated to grow.
The factor that is expected to inhibit the growth of the market is the limitations associated with the hematology diagnostics. The factors which limit the growth of the market include that not all the blood tests provide the final diagnosis of disease, they are only used to detect for abnormalities, the cost of diagnostic tests and the lack of insurance coverage.
Some of the major companies that are present in the global hematology diagnostics market are Beckman Coulter, Inc., Abbott, HORIBA, Ltd., Sysmex Corporation, Instrumentation Laboratory, Siemens AG, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., HemoCue and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and other players.
o Fully Automated Analyzers
o Semi-Automated Analyzers
o Flow Cytometers
By End User
· Diagnostic Centers
· Hospitals and Clinics
· Academic and Research Institutions
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
At present, consumables account for the largest proportion of the market and this is not expected to change because it is one of the most used components in the hematology diagnostics. This is because it is utilized more for the diagnosis of increasing hematological disorders. Increasing demand for early detection and increasing volume of tests being undertaken are further increasing the growth.
The global hematology diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are the two largest markets for hematology diagnostics at present and they are expected to account for a large proportion of the market in the forecast period as well. This is due to the high prevalence of the hematological disorders in the region and also the ongoing research & development initiatives for the development of advanced diagnostics. In the Asia Pacific region, Japan is expected to provide the largest market opportunity. This is because Japan has a highly developed healthcare system and also a large proportion of the geriatric population. An emerging market such as India and China, are anticipated to fuel considerable market growth.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm